Searched for
ADITI KARE PANANDIKAR
Decoded: How India makes affordable drugs for developed world, but ‘deadly’ medicines for developing countriesIndia is called the 'pharmacy of the world' because it makes and exports drugs worth millions of dollars to many countries. But recent inci...- Teva launches Indoco Remedies-developed generic drug in USThe product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its ...
- Indoco Remedies wins tenders worth Rs 140 crore for supply of kidney stones treatment drug in GermanyAditi Kare Panandikar, Managing Director - Indoco Remedies said: "This is Indoco's first own label product in Europe. Germany is totally te...
- Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drugIn a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP i...
- Indoco Remedies receives EIR from USFDAIndoco Remedies got "establishment inspection report (EIR) for its Clinical Research Organisation, AnaCipher, located at Hyderabad for the ...
- Indoco Remedies gets EIR from USFDA for 2 plants in Goa"We are happy to receive the EIR in less than two months from the date of inspection," Indoco Remedies MD Aditi Kare Panandikar said.
- USFDA retains OAI status for Indoco's Goa plantThe facility was inspected by the USFDA in January 2019.
- Indoco Remedies shares soar 12% on USFDA nod for Goa plantThe stock soared 11 per cent to settle at Rs 296.75 on BSE. During the day, it jumped 17.44 per cent to Rs 314.
- Indoco Remedies gets USFDA nod for Goa solid dosages plantIndoco Remedies today said it has received an approval from the US Food and Drug Administration (USFDA) for its solid dosages manufacturing...
- Indoco Remedies Q1 profit up 118%; to file 10 ANDAs in FY15Compared to industry average growth rate of 8.8%, the company's domestic formulation business registered a 24.4 percent revenue growth.
- Indoco Remedies eyes 25% annual exports growth in 5 yearsPharma company Indoco Remedies Ltd today said it is looking at growing its international business by over 25 per cent year-on-year in the n...
- We’re enhancing our capacity to 10 bn tablets: Aditi Kare Panandikar, Indoco RemediesET Now catches up with Aditi Kare Panandikar, Indoco Remedies Ltd, for her views on the formulation drugmaker’s production network, FDA app...
Load More
